FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050310147> ?p ?o ?g. }

• W2050310147 endingPage "101" @default.
• W2050310147 startingPage "95" @default.
• W2050310147 abstract "This study sought to prospectively observe the morphologic and clinical natural history of severe atherosclerotic disease of the thoracic aorta as defined by transesophageal echocardiography. Atherosclerosis of the thoracic aorta has been shown to be highly associated with risk for embolic events in transesophageal studies, but the natural history of the disease under clinical conditions has not been reported. During a 20-month period, 191 of 264 patients undergoing transesophageal echocardiography had adequate visualization of the aorta to allow atherosclerotic severity to be graded as follows: grade I= normal (44 patients); grade II= intimal thickening (52 patients); grade III= atheroma <5 mm (62 patients); grade IV= atheroma ≥5 mm (19 patients); grade V= mobile lesion (14 patients). All available patients with grades IV (8 patients) and V (10 patients) disease as well as a subgroup of 12 patients with grade III disease had follow-up transesophageal echocardiographic studies (mean [±SD] 11.7 ± 0.9 months, range 6 to 22). Of 30 patients undergoing follow-up transesophageal echocardiographic studies, 20 (66%) had no change in atherosclerotic severity grade. Of the remaining 10 patients, atherosclerotic severity progressed one grade in 7 and decreased in 3 with resolved mobile lesions. Of 18 patients with grade IV or V disease of the aorta who underwent a follow-up study, 11 (61%) demonstrated formation of new mobile lesions. Of 10 patients with grade V disease on initial study who underwent follow-up study, 7 (70%) demonstrated resolution of a specific previously documented mobile lesion. However, seven patients (70%) with grade V disease also demonstrated development of a new mobile lesion. Of 33 patients with grade IV or V disease, 8 (24%) died during the study period, and 1 (3%) had a clinical embolic event. The presence of severe atherosclerotic disease of the thoracic aorta as defined by transesophageal echocardiography is associated with a high mortality rate. Although the morphologic natural history of the disease process itself is marked by stability over a 1-year period, individual lesion morphology is dynamic, with formation and resolution of mobile components occurring frequently over the same period. The dynamic nature of individual lesion morphology potentially enhances the possibility of developing a successful therapeutic strategy." @default.
• W2050310147 created "2016-06-24" @default.
• W2050310147 creator A5002939213 @default.
• W2050310147 creator A5016501769 @default.
• W2050310147 creator A5024441952 @default.
• W2050310147 creator A5026175863 @default.
• W2050310147 creator A5055392545 @default.
• W2050310147 creator A5056766398 @default.
• W2050310147 date "1996-01-01" @default.
• W2050310147 modified "2023-10-06" @default.
• W2050310147 title "Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study" @default.
• W2050310147 cites W1778443233 @default.
• W2050310147 cites W1848464647 @default.
• W2050310147 cites W1965408926 @default.
• W2050310147 cites W1969393788 @default.
• W2050310147 cites W1971381103 @default.
• W2050310147 cites W1972827394 @default.
• W2050310147 cites W1975043637 @default.
• W2050310147 cites W1979089130 @default.
• W2050310147 cites W1986544508 @default.
• W2050310147 cites W1998069480 @default.
• W2050310147 cites W2000991364 @default.
• W2050310147 cites W2002222608 @default.
• W2050310147 cites W2003414063 @default.
• W2050310147 cites W2004303510 @default.
• W2050310147 cites W2009784171 @default.
• W2050310147 cites W2015612053 @default.
• W2050310147 cites W2019548354 @default.
• W2050310147 cites W2020545937 @default.
• W2050310147 cites W2026183534 @default.
• W2050310147 cites W2027473028 @default.
• W2050310147 cites W2027589119 @default.
• W2050310147 cites W2030363575 @default.
• W2050310147 cites W2032312761 @default.
• W2050310147 cites W2039817105 @default.
• W2050310147 cites W2047414050 @default.
• W2050310147 cites W2051968895 @default.
• W2050310147 cites W2060946128 @default.
• W2050310147 cites W2069714065 @default.
• W2050310147 cites W2070691578 @default.
• W2050310147 cites W2072465746 @default.
• W2050310147 cites W2074809972 @default.
• W2050310147 cites W2078966370 @default.
• W2050310147 cites W2081915787 @default.
• W2050310147 cites W2137570167 @default.
• W2050310147 cites W2149087848 @default.
• W2050310147 cites W2319209248 @default.
• W2050310147 cites W2324712847 @default.
• W2050310147 cites W2328371604 @default.
• W2050310147 cites W3194355700 @default.
• W2050310147 cites W4252241269 @default.
• W2050310147 cites W4294620984 @default.
• W2050310147 doi "https://doi.org/10.1016/0735-1097(95)00431-9" @default.
• W2050310147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8522717" @default.
• W2050310147 hasPublicationYear "1996" @default.
• W2050310147 type Work @default.
• W2050310147 sameAs 2050310147 @default.
• W2050310147 citedByCount "146" @default.
• W2050310147 countsByYear W20503101472012 @default.
• W2050310147 countsByYear W20503101472013 @default.
• W2050310147 countsByYear W20503101472014 @default.
• W2050310147 countsByYear W20503101472015 @default.
• W2050310147 countsByYear W20503101472016 @default.
• W2050310147 countsByYear W20503101472017 @default.
• W2050310147 countsByYear W20503101472018 @default.
• W2050310147 countsByYear W20503101472019 @default.
• W2050310147 countsByYear W20503101472020 @default.
• W2050310147 countsByYear W20503101472021 @default.
• W2050310147 countsByYear W20503101472022 @default.
• W2050310147 crossrefType "journal-article" @default.
• W2050310147 hasAuthorship W2050310147A5002939213 @default.
• W2050310147 hasAuthorship W2050310147A5016501769 @default.
• W2050310147 hasAuthorship W2050310147A5024441952 @default.
• W2050310147 hasAuthorship W2050310147A5026175863 @default.
• W2050310147 hasAuthorship W2050310147A5055392545 @default.
• W2050310147 hasAuthorship W2050310147A5056766398 @default.
• W2050310147 hasBestOaLocation W20503101471 @default.
• W2050310147 hasConcept C126322002 @default.
• W2050310147 hasConcept C126838900 @default.
• W2050310147 hasConcept C141071460 @default.
• W2050310147 hasConcept C163276114 @default.
• W2050310147 hasConcept C164705383 @default.
• W2050310147 hasConcept C2776864027 @default.
• W2050310147 hasConcept C2779318932 @default.
• W2050310147 hasConcept C2779980429 @default.
• W2050310147 hasConcept C2781156865 @default.
• W2050310147 hasConcept C71924100 @default.
• W2050310147 hasConceptScore W2050310147C126322002 @default.
• W2050310147 hasConceptScore W2050310147C126838900 @default.
• W2050310147 hasConceptScore W2050310147C141071460 @default.
• W2050310147 hasConceptScore W2050310147C163276114 @default.
• W2050310147 hasConceptScore W2050310147C164705383 @default.
• W2050310147 hasConceptScore W2050310147C2776864027 @default.
• W2050310147 hasConceptScore W2050310147C2779318932 @default.
• W2050310147 hasConceptScore W2050310147C2779980429 @default.
• W2050310147 hasConceptScore W2050310147C2781156865 @default.
• W2050310147 hasConceptScore W2050310147C71924100 @default.
• W2050310147 hasIssue "1" @default.

• next